Learn more

CHAN ZUCKERBERG BIOHUB INC

Overview
  • Total Patents
    43
  • GoodIP Patent Rank
    35,352
About

CHAN ZUCKERBERG BIOHUB INC has a total of 43 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HENAN BIOENGINEERING RES CENTER, KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MÜNCHEN and GAY STEFFEN.

Patent filings per year

Chart showing CHAN ZUCKERBERG BIOHUB INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Clarke Michael F 9
#2 Quake Stephen R 9
#3 Croote Derek 6
#4 Hsieh Robert W 6
#5 Nadeau Kari 5
#6 Darmanis Spyros 5
#7 Camunas-Soler Joan 4
#8 Kim Peter S 4
#9 Soh Hyongsok Tom 4
#10 Cornfield David N 4

Latest patents

Publication Filing date Title
WO2021062063A1 Improved variants of tev protease for biotechnological applications
US2021071179A1 Mobile-crispri plasmids and related methods
WO2020257519A1 Bacteria-engineered to elicit antigen-specific t-cells
WO2020251973A1 Compositions and methods for rna interference
WO2020243200A1 Method for multiplexed detection of nucleic acids using spectrally encoded beads
WO2020243160A1 Methods and compositions for multiple-parameter single-cell analysis using spectrally encoded microbeads
WO2020223160A1 A novel chromatin-opening element for stable long term gene expression
WO2020210225A1 Barcoded clonal tracking of gene targeting in cells
WO2020190700A1 Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer
US10684287B1 Methods related to a structure of high-affinity human PD-1/PD-L2 complex
WO2020146899A1 Targeted in vivo genome modification
WO2020106999A1 High-complexity synthetic gut bacterial communities
WO2020086764A1 Optical real-time biosensor
WO2020086762A1 Compositions and methods involving aptamer switch polynucleotides
WO2020081808A1 Methods and compositions involving thermostable cas9 protein variants
WO2020033491A1 Antibodies against dengue virus and related methods
WO2020033438A1 Nucleic acid sequence enrichment by defined nucleic acid-directed endonuclease digestion
WO2020009998A1 Method to perform high-throughput single cell genomic and phenotypic analyses
WO2019236571A1 Compositions and methods involving non-natural aptamer libraries
WO2019236548A1 Compositions and methods for screening aptamers